Chiesi Ventures is a venture capital firm that invests in early stage opportunities operating in the area of rare and orphan disorders.
Chiesi Ventures is a venture capital firm that invests in early stage opportunities operating in the area of rare and orphan disorders. The company funds research and development opportunities for therapies of rare diseases and aims to improve the quality of diagnosis, disease management, care and therapy to all patients affected by rare diseases. It also aims to accelerate the expansion of the Chiesi network in the U.S. among universities, venture capital investors, rare disease patient organizations, and entrepreneurial companies developing treatments for rare diseases.On September 2, 2014, Chiesi Ventures and A. M. Pappas & Associates announced a strategic collaboration.Chiesi Ventures was founded on September 2, 2014, and is headquartered in Parma, Italy with presence in the United States. It is owned by Chiesi Group.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Mar 22, 2021
Aura Biosciences
|
Series Unknown | $80M | Biotechnology | — |
Dec 21, 2017
Aura Biosciences
|
Series C | $30M | Biotechnology | — |
Mar 5, 2015
Aura Biosciences
|
Series B | $21M | Biotechnology | — |